Lv1
30 积分 2026-03-10 加入
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials
14天前
已完结
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study
14天前
已完结
Extensive Oral Ulcerations After Stem Cell Transplant
1个月前
已完结
Chemotherapy-Induced Peripheral Neuropathy
1个月前
已完结
皖公网安备34019202002308
